Northern Trust’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-12,493
Closed -$16K 4278
2016
Q2
$16K Hold
12,493
﹤0.01% 4136
2016
Q1
$16K Hold
12,493
﹤0.01% 4148
2015
Q4
$18K Hold
12,493
﹤0.01% 4180
2015
Q3
$19K Sell
12,493
-2,872
-19% -$4.58K ﹤0.01% 4187
2015
Q2
$26K Sell
15,365
-4,276
-22% -$7.14K ﹤0.01% 4126
2015
Q1
$42K Hold
19,641
﹤0.01% 4173
2014
Q4
$27K Hold
19,641
﹤0.01% 4162
2014
Q3
$16K Hold
19,641
﹤0.01% 4224
2014
Q2
$44K Hold
19,641
﹤0.01% 4123
2014
Q1
$59K Hold
19,641
﹤0.01% 4037
2013
Q4
$62K Sell
19,641
-300
-2% -$837 ﹤0.01% 3948
2013
Q3
$55K Buy
+19,941
New +$54K ﹤0.01% 3925

Other funds holding ECTE

Northern Trust's ECTE Position: Q3 2016 in Review

Northern Trust sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 12,493 shares — an estimated $16K sold.

Northern Trust first reported a position in ECTE in Q3 2013 and held it in 12 quarters. The position peaked at $62K in Q4 2013. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

  • Northern Trust reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
  • Northern Trust sold 12,493 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $16K.
  • Northern Trust first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q3 2013 and held it in 12 quarters.
  • Northern Trust's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $62K in Q4 2013.
  • 2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Northern Trust's 13F filing for Q3 2016, filed 10 Nov 2016.